Brand Name: POSLUMA. Generic Name: (flotufolastat F 18). POSLUMA (flotufolastat F 18) is used with positron emission tomography imaging in certain patients with prostate cancer.
POSLUMA is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer:
- with suspected metastasis who are candidates for initial definitive therapy
- with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level.
| Brand Name: | POSLUMA |
| Generic Name: | flotufolastat F 18 |
| Strength: | Injection:296 MBq/mL to 5,846 MBq/mL (8 mCi/mL to 158 mCi/mL) as flotufolastat F 18 gallium in approximately 25 mL at end of synthesis in a multiple-dose vial. |
| Manufacturer: | Blue Earth Diagnostics Ltd |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “POSLUMA (flotufolastat F 18)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for POSLUMA (flotufolastat F 18) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.
